title: Reply.
authors.affiliation: Kyorin University School of Medicine, Tokyo, Japan. Electronic address: aokada@eye-center.org.
authors.forename: Annabelle A
authors.initials: AA
authors.lastname: Okada
authors.affiliation: Kyorin University School of Medicine, Tokyo, Japan.
authors.forename: Akiko
authors.initials: A
authors.lastname: Yamamoto
authors.affiliation: Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Koizumi
authors.affiliation: Fukushima Medical University, Fukushima, Japan.
authors.forename: Mariko
authors.initials: M
authors.lastname: Kano
authors.affiliation: Fukushima Medical University, Fukushima, Japan.
authors.forename: Masaaki
authors.initials: M
authors.lastname: Saito
authors.affiliation: Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Maruko
authors.affiliation: Fukushima Medical University, Fukushima, Japan.
authors.forename: Tetsuju
authors.initials: T
authors.lastname: Sekiryu
authors.affiliation: Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Iida
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011127:Polyps / Q000188:drug therapy*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; D040262:Receptors, Vascular Endothelial Growth Factor